Robert Crayhon

Drug prices skyrocket, reports USA Today. I wonder what the conversation went like in the meeting at Questcor when the anti-spasm drug Acthar went up astronomically: ”I don’t think we should charge $1,650 a vial any more.  How about…$23,000 a vial.” ”Sure.” This, at least, is the best guess one can come up with for the reasoning.